Cancer Biomarkers Market Share

Statistics for the 2023 & 2024 Cancer Biomarkers market share, created by Mordor Intelligence™ Industry Reports. Cancer Biomarkers share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Cancer Biomarkers Industry

The cancer biomarkers market is highly competitive and consists of a few major players. Some of the companies which are currently dominating the market are 23andMe, Abbott Laboratories Inc., Agilent Technologies, Ambry Genetics, Biomerieux, Celera Corporation (Quest Diagnostics), F. Hoffmann-La Roche Ltd, Hologic Inc., Illumina Inc., and Thermo Fisher Scientific, among others, hold substantial shares in the market.

Cancer Biomarkers Market Leaders

  1. Abbott Laboratories Inc.

  2. Thermo Fisher Scientific

  3. Biomerieux

  4. Illumina Inc.

  5. F. Hoffmann-La Roche Ltd

*Disclaimer: Major Players sorted in no particular order

Cancer Biomarkers Market Concentration

Cancer Biomarkers Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)